Paid Clinical Trials in Vermont

Dr. Ahmed Zayed

Written by Dr. Ahmed Zayed

Board-certified Physician | Graduate w/ Honors Faculty of Medicine | Alexandria, Egypt

Clinical research in Vermont is here to test the safety and efficacy of new interventions, drugs, and therapies. Volunteers make treatment discoveries possible. By diversifying the clinical trials, experts can improve patient care for all kinds of diseases.

Be the missing piece in medical breakthrough. We are here to help you enlist for a clinical trial. 

Clinical Trials For Disease Areas in Vermont 

There are over 1,000 active clinical research trials in Vermont across different specialty areas. Every research opportunity provides more data that can help prevent, diagnose, or treat a disease. 

Some of the most notable disease areas studied in Vermont are psychiatric diseases, antibiotic resistance, metabolic disorders, respiratory diseases, musculoskeletal conditions, and neurological complications. 

Recently, scientists at the University of Vermont received a $450,000 grant to continue their research. The clinical study could eventually find a novel approach to treat rare, more aggressive forms of breast cancer. 

Your contribution is equally valuable. Volunteer for a clinical trial and help shape the treatments of tomorrow. Browse the list below for active and future trials. 

By participating in paid clinical trials in Vermont, you get immediate access to treatments that are not available anywhere else. Not only that, but you also receive compensation for your services.

You can get paid, or get other benefits. Such as free medical treatment, covered travel and food expenses, vouchers, etc. Check the details of VT paid clinical trials before applying. 

Clinical Trials For Health Volunteers in Vermont 

Clinical trials are the safest and fastest ways to find treatments that work. Each trial uses healthy or sick volunteers to answer scientific questions. 

But, before a new drug becomes available to the public, research teams in Vermont need to test it to see if it works. With your help, they can make the latest treatments a reality. 

Seize the opportunity to shape the future of medicine. Apply for a clinical trial now.

Integrated Cancer Repository for Cancer Research
Recruiting
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer... Read More
Gender:
ALL
Ages:
Between 19 years and 110 years
Trial Updated:
06/04/2025
Locations: Rutland Regional Medical Center, Rutland, Vermont
Conditions: Pancreatic Cancer, Thyroid Cancer, Lung Cancer, Esophageal Cancer, Thymus Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Bile Duct Cancer, Duodenal Cancer, Gallbladder Cancer, Gastric Cancer, Liver Cancer, Small Intestine Cancer, Peritoneal Surface Malignancies, Familial Adenomatous Polyposis, Lynch Syndrome, Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer, Ureter Cancer, Urethral Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Lip Cancer, Oral Cavity Cancer, Nasopharyngeal Cancer, Oropharyngeal Cancer, Paranasal Sinus Cancer, Nasal Cavity Cancer, Salivary Gland Cancer, Skin Cancer, Mesothelioma, Breast Cancer, Leukemia, Melanoma, Sarcoma, Unknown Primary Tumor, Multiple Myeloma, Ovarian Cancer, Endometrial Cancer, Vaginal Cancer, Neuroendocrine Tumors, Plasma Cell Dyscrasia, Healthy Control, Gastrointestinal Stromal Tumors, Central Nervous System Tumor, Central Nervous System Cancer
Avocado and Postprandial Responses
Recruiting
The purpose of this study is to see how adding avocado to a breakfast meal affects blood sugar control and signals of hunger and fullness after eating. The investigators will test the effects of 3 breakfast meals on blood sugar control and signals of hunger and fullness after eating: 1. Whole-wheat bread and strawberry jam 2. Whole-wheat bread, strawberry jam, and avocado 3. Whole-wheat bread and strawberry jam (meal enriched with fat and fiber to mimic that of an avocado) Participants will u... Read More
Gender:
ALL
Ages:
Between 21 years and 65 years
Trial Updated:
03/24/2025
Locations: Clinical Research Center, University of Vermont Medical Center, Burlington, Vermont
Conditions: Healthy, Healthy Volunteer, Healthy Volunteers, Healthy Adult, Healthy Male and Female Subjects, Healthy Subjects, Healthy Volunteers Only, Healthy Non-smokers

Medical Discoveries and Innovation in Vermont

While Vermont may not have been the epicenter of medical innovation on a global scale, it does have a fair share of notable contributions. Here are some of the medical achievements that helped shape the field of medicine. 

  • Mental Health Advocacy – Vermont is at the forefront of promoting mental health and addiction recovery. Many educates, advocates and support programs have helped patients get access to adequate mental health treatment so that they can build better lives. 
  • Genetic Research – The University of Vermont provides valuable data for genetic studies. That includes studies on genetic diseases and personalized medicine. 
  • Prosthetic Technology – Experts and engineering students are a valuable component of the early development of artificial limbs. They are using 3D printers in Vermont clinical research to create and test custom-fitted prosthetics. These prosthetics are more affordable to the general public.

Why Vermont Is A Great Place For Clinical Research 

Minorities are underrepresented in clinical trials. Vermont is a good place for clinical research because it helps diversify the pool of volunteers. Although 92.2% of its residents are White, there are other minorities who live here. About 2.2% are Hispanic, 2% are Asian, 1.9% are Multiracial, 1.3% are Black, and 0.3% are American Indian.